Table 4. Univariate associations for the use and efficacy of vitamins and antioxidants, celiac plexus block, and octreotide in chronic pancreatitis patients in the North American Pancreatitis Study 2.
Attribute | % in sample (N=516) |
VITAMINS/ANTIOXIDANTS | CELIAC PLEXUS BLOCK | OCTREOTIDE | |||
---|---|---|---|---|---|---|---|
% Tried | % Effective | % Tried | % Effective | % Tried | % Effective | ||
Gender | |||||||
Male | 51.9 | 16.0 | 16.3 | 5.6 | 40.0 | 5.2 | 64.3 |
Female | 48.1 | 11.3 | 10.7 | 7.7 | 36.8 | 5.7 | 42.9 |
| |||||||
Age: | * | ||||||
<35 | 18.2 | 17.0 | 25.0 | 6.4 | 66.7 | 5.3 | 20.0 |
35-44 | 21.3 | 11.8 | 7.7 | 9.1 | 40.0 | 6.4 | 57.1 |
45-64 | 44.2 | 13.6 | 16.1 | 7.0 | 25.0 | 5.7 | 76.9 |
65+ | 16.3 | 13.1 | 0.0 | 2.4 | 50.0 | 3.6 | 0.0 |
| |||||||
Race | |||||||
White | 84.9 | 13.9 | 14.8 | 6.4 | 39.3 | 5.3 | 56.5 |
Other | 15.1 | 12.8 | 10.0 | 7.7 | 33.3 | 6.4 | 40.0 |
| |||||||
Etiology | |||||||
Alcohol | 43.8 | 12.4 | 3.6 | 6.6 | 40.0 | 3.5 | 75.0 |
Obstructive | 8.7 | 15.6 | 28.6 | 2.2 | 100.0 | 8.9 | 50.0 |
Idiopathic | 28.9 | 16.8 | 24.0 | 9.4 | 35.7 | 7.4 | 54.5 |
Other | 18.6 | 11.5 | 9.1 | 4.2 | 25.0 | 5.2 | 40.0 |
| |||||||
Pain | |||||||
Yes | 76.7 | 13.4 | 11.3 | 7.6 | 40.0 | 6.3 | 56.0 |
No | 23.3 | 15.0 | 22.2 | 3.3 | 25.0 | 2.5 | 33.3 |
| |||||||
Pain | |||||||
No pain | 23.3 | 15.0 | 22.2 | 3.3 | 25.0 | 2.5 | 50.0 |
Constant | 43.2 | 13.9 | 12.9 | 12.6 | 35.7 | 6.7 | 60.0 |
Intermittent | 33.5 | 12.7 | 9.1 | 1.2 | 100.0 | 5.8 | 33.3 |
| |||||||
Pain | * | ||||||
No pain | 23.3 | 15.0 | 22.2 | 3.3 | 25.0 | 2.5 | 33.3 |
Mild-moderate | 17.1 | 11.4 | 10.0 | 4.6 | 75.0 | 6.8 | 33.3 |
Severe | 59.7 | 14.0 | 11.6 | 8.4 | 34.6 | 6.2 | 63.2 |
| |||||||
Exocrine Insufficiency (n=480) | * | ||||||
Yes | 29.0 | 15.8 | 18.2 | 8.6 | 25.0 | 1.4 | 54.2 |
No | 71.0 | 12.0 | 7.3 | 5.6 | 47.4 | 7.0 | 100.0 |
| |||||||
Endocrine Insufficiency (n=480) | |||||||
Yes | 26.2 | 13.1 | 11.8 | 7.7 | 30.0 | 3.9 | 60.0 |
No | 73.8 | 13.1 | 10.4 | 6.0 | 45.5 | 6.0 | 54.6 |
p < 0.05
“% in sample” - proportion of overall study sample (i.e. patients in whom any medical, endoscopic or surgical treatment modality was utilized, n = 516); “% tried” – proportion of individual subgroup in whom treatment was tried; “% effective” – among patients who received treatment, proportion in whom it was considered to be effective.